Clinical Trial Update: Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence [Phase 3]

View source ↗

Summary

A Phase 3 trial of topiramate for alcohol dependence and borderline personality disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Borderline Personality Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Elizabeth Ralevski | Conditions: Alcohol Dependence, Borderline Personality Disorder | Phase 3 | Status: WITHDRAWN